Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M S O'Dorisio

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
The American Journal of Medicine|December 22, 1986
Neuropeptides and gastrointestinal immunityM S O'Dorisio
Federation Proceedings|January 1, 1987
Biochemical characteristics of receptors for vasoactive intestinal polypeptide in nervous, endocrine, and immune systemsM S O'Dorisio
The International Journal of Neuroscience|January 1, 1988
Neuropeptide modulation of the immune response in gut associated lymphoid tissueM S O'Dorisio
Digestion|January 1, 1996
Clinical use of somatostatin analogues in paediatric oncologyA R Albers, M S O'Dorisio
The Journal of Biological Chemistry|January 25, 1985
Covalent cross-linking of vasoactive intestinal polypeptide to its receptors on intact human lymphoblastsC L Wood, M S O'Dorisio
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1985
Induction of cAMP-dependent protein kinase I during human monocyte differentiationG D Wenger, M S O'Dorisio
Molecular Immunology|June 1, 1989
Comparison of vasoactive intestinal peptide-mediated protein phosphorylation in human lymphoblasts and colonic epithelial cellsM S O'Dorisio, L B Campolito
Acta Oncologica (Stockholm, Sweden)|January 1, 1991
Modulation of immune function by intestinal neuropeptidesL P Sirinek, M S O'Dorisio
Annals of the New York Academy of Sciences|February 24, 2001
Vasoactive intestinal peptide (VIP) receptor type 2 (VPAC2) is the predominant receptor expressed in human thymocytesM L Lara-Marquez, M S O'Dorisio, B Karacay
Journal of Clinical Immunology|September 1, 1995
Accumulation of donor-specific cytotoxic T cells in intestinal lymphoid tissues following intestinal transplantationL P Sirinek, M S O'Dorisio, D J Dunaway
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
The American Journal of Medicine|December 22, 1986
Neuropeptides and gastrointestinal immunityM S O'Dorisio
Federation Proceedings|January 1, 1987
Biochemical characteristics of receptors for vasoactive intestinal polypeptide in nervous, endocrine, and immune systemsM S O'Dorisio
The International Journal of Neuroscience|January 1, 1988
Neuropeptide modulation of the immune response in gut associated lymphoid tissueM S O'Dorisio
Digestion|January 1, 1996
Clinical use of somatostatin analogues in paediatric oncologyA R Albers, M S O'Dorisio
The Journal of Biological Chemistry|January 25, 1985
Covalent cross-linking of vasoactive intestinal polypeptide to its receptors on intact human lymphoblastsC L Wood, M S O'Dorisio
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1985
Induction of cAMP-dependent protein kinase I during human monocyte differentiationG D Wenger, M S O'Dorisio
Molecular Immunology|June 1, 1989
Comparison of vasoactive intestinal peptide-mediated protein phosphorylation in human lymphoblasts and colonic epithelial cellsM S O'Dorisio, L B Campolito
Acta Oncologica (Stockholm, Sweden)|January 1, 1991
Modulation of immune function by intestinal neuropeptidesL P Sirinek, M S O'Dorisio
Annals of the New York Academy of Sciences|February 24, 2001
Vasoactive intestinal peptide (VIP) receptor type 2 (VPAC2) is the predominant receptor expressed in human thymocytesM L Lara-Marquez, M S O'Dorisio, B Karacay
Journal of Clinical Immunology|September 1, 1995
Accumulation of donor-specific cytotoxic T cells in intestinal lymphoid tissues following intestinal transplantationL P Sirinek, M S O'Dorisio, D J Dunaway
Pageof 7